Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1971 1
1972 1
1973 1
1982 4
1983 4
1984 4
1985 2
1986 1
1987 1
1988 1
1989 1
1990 3
1991 4
1992 1
1993 2
1994 3
1995 7
1996 4
1997 3
1998 3
1999 3
2000 2
2001 6
2002 8
2003 7
2004 5
2005 4
2006 6
2007 7
2008 7
2009 4
2010 5
2011 11
2012 6
2013 9
2014 8
2015 7
2016 6
2017 16
2018 17
2019 13
2020 10
2021 22
2022 19
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
Occult Hepatitis B Virus Infection: An Update.
Saitta C, Pollicino T, Raimondo G. Saitta C, et al. Among authors: raimondo g. Viruses. 2022 Jul 8;14(7):1504. doi: 10.3390/v14071504. Viruses. 2022. PMID: 35891484 Free PMC article. Review.
Effects of psychotropic drugs on seizure threshold.
Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Pisani F, et al. Among authors: di raimondo g. Drug Saf. 2002;25(2):91-110. doi: 10.2165/00002018-200225020-00004. Drug Saf. 2002. PMID: 11888352 Review.
Hepatitis B vaccination.
Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR. Romanò L, et al. Among authors: raimondo g. Hum Vaccin Immunother. 2015;11(1):53-7. doi: 10.4161/hv.34306. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483515 Free PMC article. Review.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Among authors: raimondo g. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma.
Giannini EG, Pieri G, Labanca S, Plaz Torres MC, Gasbarrini A, Biasini E, Campani C, Cazzagon N, Foschi FG, Mega A, Masotto A, Raimondo G, Rapaccini GL, Sacco R, Caturelli E, Guarino M, Tovoli F, Vidili G, Brunetto MR, Nardone G, Svegliati-Baroni G, Magalotti D, Azzaroli F, Cabibbo G, Di Marco M, Sangiovanni A, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Study Group. Giannini EG, et al. Among authors: raimondo g. Dig Liver Dis. 2022 Sep;54(9):1215-1221. doi: 10.1016/j.dld.2022.03.002. Epub 2022 Mar 27. Dig Liver Dis. 2022. PMID: 35354543
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison.
Famularo S, Donadon M, Cipriani F, Giuliante F, Ferri S, Celsa C, Ferrero A, Foschi FG, Baiocchi GL, Biasini E, Campani C, Valle RD, Pelizzaro F, Baroni GS, Raimondo G, Mega A, Chiarelli M, Maestri M, Gasbarrini A, Jovine E, Grazi GL, Rapaccini GL, Ruzzenente A, Morisco F, Sacco R, Memeo R, Crespi M, Antonucci A, Bernasconi DP, Romano F, Griseri G, Aldrighetti L, Torzilli G, Trevisani F; ITA.LI.CA Group and HE.RC.O.LE.S. Group. Famularo S, et al. Among authors: raimondo g. Ann Surg. 2022 Apr 1;275(4):743-752. doi: 10.1097/SLA.0000000000005373. Ann Surg. 2022. PMID: 35081572
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors.
Stefanini B, Bucci L, Santi V, Reggidori N, Rampoldi D, Lani L, Granito A, Sangiovanni A, Cabibbo G, Farinati F, Campani C, Foschi FG, Svegliati-Baroni G, Raimondo G, Gasbarrini A, Mega A, Biasini E, Sacco R, Morisco F, Caturelli E, Vidili G, Azzaroli F, Giannini EG, Rapaccini GL, Brunetto MR, Masotto A, Nardone G, Di Marco M, Magalotti D, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Stefanini B, et al. Among authors: raimondo g. Dig Liver Dis. 2022 Nov;54(11):1563-1572. doi: 10.1016/j.dld.2022.07.003. Epub 2022 Jul 27. Dig Liver Dis. 2022. PMID: 35906166
Occult HBV infection.
Raimondo G, Caccamo G, Filomia R, Pollicino T. Raimondo G, et al. Semin Immunopathol. 2013 Jan;35(1):39-52. doi: 10.1007/s00281-012-0327-7. Epub 2012 Jul 26. Semin Immunopathol. 2013. PMID: 22829332 Free PMC article. Review.
237 results